This is to acknowledge that Giuseppe Cotellessa Attended a one-hour webinar and a Q&A sessione entitled " From dose escalation to dose optimization through Model-Informed Drug Development " / Si attesta che Giuseppe Cotellessa ha partecipato ad un webinar della durata di un'ora ed ad una sessione di domande e risposte dal titolo "Dall'escalation della dose all'ottimizzazione della dose attraverso lo sviluppo di farmaci basato su modelli (Model-Informed Drug Development)" /#2/11/2026 bis
This is to acknowledge that
Giuseppe Cotellessa
Attended a one-hour webinar and a Q&A sessione entitled
" From dose escalation to dose optimization through Model-Informed Drug Development " /
Si attesta che
Giuseppe Cotellessa
ha partecipato ad un webinar della durata di un'ora ed ad una sessione di domande e risposte dal titolo
"Dall'escalation della dose all'ottimizzazione della dose attraverso lo sviluppo di farmaci basato su modelli (Model-Informed Drug Development)" /#2/11/2026 bis
Dott. Giuseppe Cotellessa
From dose escalation to dose optimization through Model-Informed Drug Development
Artificial Intelligence (AI) has transformed drug discovery, enabling researchers to generate more candidate molecules than ever before. But as design scales, a new challenge has emerged: traditional validation workflows were never built to keep pace with AI.
To address this growing gap, GenScript developed the Validation Engine for AI-Driven Drug Discovery: an integrated platform designed to help discovery teams rapidly transform AI-generated designs into decision-ready biological data.
Join SelectScience® and Dr. Witold Jaworek to learn how GenScript's Validation Engine combines industrial-scale protein production, flexible expression strategies, high-throughput validation, and AI-ready data delivery to accelerate Design- Build-Test-Learn (DBTL) cycles and support faster, more confident discovery decisions.
Dr. Jaworek will also explore how next-generation validation infrastructure helps researchers move beyond the bottlenecks of traditional workflows and unlock more value from AI-driven discovery programs.
Whether you are developing antibodies, advancing biologics, building AI discovery platforms, or supporting translational research, you will gain insights into how faster validation enables better decisions and accelerates discovery.
ITALIANO

Commenti
Posta un commento